By Isabelle Lee Good morning. Powell signals a delay to rate cuts. China tries to settle nerves about its new stock exchange rules. And the US considers more sanctions against Iran. Here’s what’s moving markets. — Isabelle Lee Staying high Federal Reserve Chair Jerome Powell said recent inflation data have indicated it will likely take longer for the central […]
By Hannah Green A 10-year-old AI drug discovery company is moving its headquarters from New York to Massachusetts. Insilico Medicine has leased space at 1000 Massachusetts Ave. in Cambridge. The company was previously based out of an office at Cure, a New York City healthcare innovation campus, where it plans to keep a presence as it expands in […]
By Lucia Maffei Can iRobot continue to spur robotics innovation even as its research and development spending is on the decline? That’s one of the big questions that emerged in the aftermath of the implosion of iRobot’s merger deal with Amazon, which forced the Bedford-based Roomba-maker to chart an alternative path to its own future while […]
By Hannah Green Novartis is once again shelling out millions to buy a subsidiary of Boston-based IFM Therapeutics. Novartis (NYSE: NVS) said on Wednesday it is acquiring all of the outstanding capital stock of IFM Due, a subsidiary company of IFM. Novartis is paying IFM $90 million upfront for this acquisition, and IFM will also be […]
By Hannah Green and Greg Ryan Gov. Maura Healey has laid out her plans to reauthorize the Life Sciences Initiative with a new $1 billion, 10-year strategy, as well as put an additional $1 billion toward making the Bay State a hub for the clean energy industry. The so-called “Life Sciences 3.0,” as well as a package of […]
By: Emily Fu North River Leerink (NRL) has announced that 100 Chestnut, a purpose-built 200,000 square feet life Science building in Somerville, MA, is 90% leased. Ultragenyx, relocating from Kendall Square, has leased 42,500 square feet to consolidate their east coast R&D. CRADL has leased 16,000 square feet to open a contract vivarium and in […]
By Hannah Green A Framingham-based biotech is relocating its headquarters to a new space closer to the center of Massachusetts’ biotech industry. BPGbio announced on Wednesday it was moving into 70,000 square feet of lab and office space at 300 Third Avenue in Waltham. The biotech company plans to move into two full floors of the […]
By Richard Berger There are early signs of recovery within the life sciences environment following a recent investment slowdown as venture capital is re-emerging, tenants are coming off the sidelines and average deal sizes are hitting all-time highs, according to a recent report from Cushman & Wakefield. Its research manager, Sandy Romero, said venture capital […]
BY REENA KARASIN Greentown Labs’ 200+ startups are developing, deploying, and commercializing climatetech solutions to decarbonize the key greenhouse-gas-emitting sectors—agriculture, buildings, electricity, manufacturing, and transportation—and build resilient communities. There’s an incredible amount of work and collaboration needed to get these technologies out of the lab and into the world, from early-stage funding, to pilot projects, to first commercial […]
By Rowan Walrath In a first for the Nobel Prize-winning gene-editing technology, a CRISPR-based drug has been approved in the U.S. The Food and Drug Administration gave the green light Friday to exa-cel, a drug made by two Boston-based companies, Vertex Pharmaceuticals Inc. (Nasdaq: VRTX) and CRISPR Therapeutics Inc. (Nasdaq: CRSP). It will be marketed under […]
